⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for autologous hematopoietic progenitor cell transplant

Every month we try and update this database with for autologous hematopoietic progenitor cell transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.NCT02909036
Multiple Myelom...
Amyloidosis
Melphalan
Pegfilgrastim
Autologous Hema...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
A Combined Cell Therapy Approach to the Treatment of NeuroblastomaNCT02745756
Neuroblastoma
Neoplasms, Nerv...
Autologous Hema...
KLH and Tumor L...
- 21 YearsH. Lee Moffitt Cancer Center and Research Institute
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.NCT02909036
Multiple Myelom...
Amyloidosis
Melphalan
Pegfilgrastim
Autologous Hema...
18 Years - 75 YearsMemorial Sloan Kettering Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: